BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, ...
Will heißen: In der Praxis braucht man schon 30 Minuten, um startend von einem niedrigen Ladestand wieder auf 80 Prozent zu kommen bei einer Peakladeleistung von maximal 200 kW. Das ist solide, aber ...
Die Ultimea Skywave X70 punktet in unserem Test durch ihre einfache Installation und die grundsätzlich gute Darstellung von Audioinhalten. Dabei geht dem System auch bei höheren Lautstärken nicht die ...
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, ...
PRINCETON, N.J., Jan. 6, 2026 /PRNewswire/ -- ETS's Praxis program, the leading provider of teacher licensure assessments, welcomes the adoption of Praxis as an approved licensure option in the state ...
Bleibt die Frage, für wen der Soundcore Nebula X1 Pro geeignet bzw. gedacht ist. Schließlich ist er nicht nur groß, schwer und unhandlich, damit also eher nichts für das heimische Wohnzimmer, sondern ...
Praxis Precision Medicines remains a Hold as valuation now reflects high expectations for ulixacaltamide and its epilepsy pipeline. Ulixacaltamide’s Essential3 data appear statistically robust, but a ...
Praxis specializes in using genetic insights to discover new therapies for neurological disorders. The biotech's efforts received a boost today when the U.S. Food and Drug Administration (FDA) granted ...
Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor. Praxis on ...
Praxis Precision Medicines Inc. (NASDAQ: PRAX) stock rose Friday after the company shared results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of ...
Praxis Precision Medicines Inc. (NASDAQ: PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10. Check out the current price of PRAX stock here. PRAX closed Thursday's regular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results